Commissioning and High Cost Drugs Conference – 27 Feb 25

High-cost medicines and how to achieve best value is as topical an issue in pharmacy as any other, especially at a time of system reform that challenges established patterns of service delivery.

In our recent conference Panel Discussion entitled Future Priorities for High Cost/Medicines Value & Pharmacy: A discussion to cover key issues and thoughts for the year ahead – our panel of prescribing experts shared their knowledge and experience of making medicines management work in practice.

To see their informative and wide-ranging answers to questions posed by our audience of prescribers and healthcare practitioners, please follow the link HERE.

PM Healthcare wishes to thank all of the following companies who funded the event through event sponsorship, sponsored satellite sessions and stand sponsorship.

Headline Sponsor
Bayer PLC

Stand Sponsors
AbbVie, Advanz Pharma UK & Ireland Ltd, AstraZeneca, LEO Pharma UK/IE, Lupin Healthcare (UK) Limited, Pfizer Limited, Teva UK Limited, UCB Pharma (UK) Limited

Back to other blogs